Alkermes plc. SEC filings ALKS

Alkermes plc. has 1,000 filings in SEC EDGAR's recent list, going back to May 4, 2017. Its latest annual report, Form ARS, was filed on Apr 6, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 3, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 3, 2026 (results of operations). The company's fiscal year ends on December 31.

Alkermes plc. SEC filings
Form Description Filed Period
4 Insider transaction Nov 3, 2026 Nov 3, 2026
144 Notice of proposed sale Nov 3, 2026 —
10-Q Quarterly report Nov 3, 2026 Sep 30, 2026
8-K Current report
Results of operations
Nov 3, 2026 Nov 3, 2026
4 Insider transaction Oct 9, 2026 Oct 8, 2026
4 Insider transaction Oct 9, 2026 Oct 7, 2026
4 Insider transaction Oct 2, 2026 Oct 2, 2026
144 Notice of proposed sale Oct 2, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Sep 21, 2026 Sep 21, 2026
3 Initial insider ownership Sep 18, 2026 Sep 14, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 16, 2026 Sep 14, 2026
4 Insider transaction Sep 3, 2026 Sep 3, 2026
144 Notice of proposed sale Sep 3, 2026 —
4 Insider transaction Sep 1, 2026 Sep 1, 2026
144 Notice of proposed sale Sep 1, 2026 —
4 Insider transaction Aug 17, 2026 Aug 17, 2026
144 Notice of proposed sale Aug 17, 2026 —
8-K Current report
Material agreement
Aug 12, 2026 Aug 12, 2026
4 Insider transaction Aug 7, 2026 Aug 5, 2026
4 Insider transaction Aug 3, 2026 Aug 3, 2026
4 Insider transaction Aug 3, 2026 Aug 3, 2026
4 Insider transaction Aug 3, 2026 Aug 3, 2026
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
144 Notice of proposed sale Aug 3, 2026 —
8-K/A Amended current report
Officer or director change
Aug 3, 2026 Feb 24, 2026
S-8 Employee stock plan registration Jul 28, 2026 —
10-Q Quarterly report Jul 28, 2026 Jun 30, 2026
8-K Current report
Results of operations
Jul 28, 2026 Jul 28, 2026
8-K Current report
Agreement ended
Jul 8, 2026 Jul 6, 2026
4 Insider transaction Jul 6, 2026 Jul 6, 2026
144 Notice of proposed sale Jul 6, 2026 —
4 Insider transaction Jul 1, 2026 Jul 1, 2026
144 Notice of proposed sale Jul 1, 2026 —
8-K Current report
Regulation FD disclosure, Other events
Jun 15, 2026 Jun 15, 2026
4 Insider transaction Jun 12, 2026 Jun 12, 2026
144 Notice of proposed sale Jun 12, 2026 —
4 Insider transaction Jun 4, 2026 Jun 4, 2026
144 Notice of proposed sale Jun 4, 2026 —
4 Insider transaction Jun 1, 2026 Jun 1, 2026
144 Notice of proposed sale Jun 1, 2026 —
4 Insider transaction May 29, 2026 May 29, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4/A Primary document May 22, 2026 May 20, 2026
4/A Primary document May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
4 Insider transaction May 22, 2026 May 20, 2026
8-K Current report
Officer or director change, Shareholder vote results
May 20, 2026 May 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) May 15, 2026 —
DEFA14A Additional proxy material May 13, 2026 —
8-K Current report
Regulation FD disclosure, Other events
May 12, 2026 May 12, 2026
10-Q Quarterly report May 5, 2026 Mar 31, 2026
8-K Current report
Results of operations
May 5, 2026 May 5, 2026
4 Insider transaction May 4, 2026 May 4, 2026
144 Notice of proposed sale May 4, 2026 —
4 Insider transaction May 1, 2026 May 1, 2026
8-K/A Amended current report May 1, 2026 Feb 12, 2026
144 Notice of proposed sale May 1, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
SCHEDULE 13G Ownership over 5% (passive) Apr 28, 2026 —
4 Insider transaction Apr 13, 2026 Apr 11, 2026
4 Insider transaction Apr 6, 2026 Apr 6, 2026
ARS Annual report to shareholders Apr 6, 2026 Dec 31, 2025
DEFA14A Additional proxy material Apr 6, 2026 —
DEF 14A Proxy statement Apr 6, 2026 May 20, 2026
144 Notice of proposed sale Apr 6, 2026 —
4 Insider transaction Apr 1, 2026 Apr 1, 2026
144 Notice of proposed sale Apr 1, 2026 —
PRE 14A Preliminary proxy statement Mar 27, 2026 May 20, 2026
SCHEDULE 13G/A Amended ownership over 5% (passive) Mar 26, 2026 —
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
4 Insider transaction Mar 4, 2026 Mar 2, 2026
144 Notice of proposed sale Mar 3, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
144 Notice of proposed sale Mar 2, 2026 —
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 27, 2026 Feb 26, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
4 Insider transaction Feb 25, 2026 Feb 23, 2026
8-K Current report
Officer or director change, Regulation FD disclosure
Feb 25, 2026 Feb 24, 2026
10-K Annual report Feb 25, 2026 Dec 31, 2025
8-K Current report
Results of operations
Feb 25, 2026 Feb 25, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
4 Insider transaction Feb 20, 2026 Feb 18, 2026
SCHEDULE 13G Ownership over 5% (passive) Feb 17, 2026 —
8-K Current report
Material agreement, Agreement ended, Acquisition or sale of assets, New debt, Regulation FD disclosure
Feb 12, 2026 Feb 12, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
4 Insider transaction Feb 6, 2026 Feb 5, 2026
4 Insider transaction Feb 2, 2026 Feb 2, 2026
4 Insider transaction Feb 2, 2026 Feb 2, 2026
144 Notice of proposed sale Feb 2, 2026 —
144 Notice of proposed sale Feb 2, 2026 —
8-K Current report
Results of operations, Regulation FD disclosure
Jan 12, 2026 Jan 12, 2026
144 Notice of proposed sale Jan 8, 2026 —
4 Insider transaction Jan 8, 2026 Jan 8, 2026
8-K Current report
Regulation FD disclosure, Other events
Jan 6, 2026 Jan 6, 2026
4 Insider transaction Jan 2, 2026 Jan 2, 2026
144 Notice of proposed sale Jan 2, 2026 —
4 Insider transaction Dec 5, 2025 Dec 3, 2025
144 Notice of proposed sale Dec 3, 2025 —
4 Insider transaction Dec 1, 2025 Dec 1, 2025
144 Notice of proposed sale Dec 1, 2025 —
8-K Current report
Material agreement, New debt, Regulation FD disclosure
Nov 19, 2025 Nov 18, 2025
8-K Current report
Regulation FD disclosure, Other events
Nov 12, 2025 Nov 12, 2025
SCHEDULE 13G Ownership over 5% (passive) Nov 10, 2025 —
4 Insider transaction Nov 3, 2025 Nov 3, 2025
144 Notice of proposed sale Nov 3, 2025 —
10-Q Quarterly report Oct 28, 2025 Sep 30, 2025
8-K Current report
Results of operations
Oct 28, 2025 Oct 28, 2025
8-K Current report
Material agreement, Results of operations, New debt, Regulation FD disclosure
Oct 22, 2025 Oct 22, 2025
4 Insider transaction Oct 15, 2025 Oct 15, 2025
144 Notice of proposed sale Oct 15, 2025 —
4 Insider transaction Oct 10, 2025 Oct 8, 2025
3 Initial insider ownership Sep 23, 2025 Sep 15, 2025
8-K Current report
Material agreement, Other events
Sep 12, 2025 Aug 15, 2025
8-K Current report
Officer or director change, Regulation FD disclosure
Sep 12, 2025 Sep 12, 2025
8-K Current report
Regulation FD disclosure
Sep 8, 2025 Sep 8, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Aug 14, 2025 —
4 Insider transaction Aug 4, 2025 Aug 3, 2025
S-8 Employee stock plan registration Jul 29, 2025 —
10-Q Quarterly report Jul 29, 2025 Jun 30, 2025
8-K Current report
Results of operations
Jul 29, 2025 Jul 29, 2025
8-K Current report
Regulation FD disclosure
Jul 21, 2025 Jul 21, 2025
4 Insider transaction Jun 10, 2025 Jun 9, 2025
4 Insider transaction Jun 10, 2025 Jun 8, 2025
144 Notice of proposed sale Jun 10, 2025 —
144 Notice of proposed sale Jun 9, 2025 —
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction Jun 2, 2025 May 31, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
4 Insider transaction May 23, 2025 May 21, 2025
8-K Current report
Officer or director change, Shareholder vote results
May 21, 2025 May 21, 2025
SCHEDULE 13G Ownership over 5% (passive) May 13, 2025 —
DEFA14A Additional proxy material May 12, 2025 —
10-Q Quarterly report May 1, 2025 Mar 31, 2025
8-K Current report
Results of operations
May 1, 2025 May 1, 2025
SCHEDULE 13G/A Amended ownership over 5% (passive) Apr 28, 2025 —
8-K Current report
Other events
Apr 16, 2025 Apr 14, 2025
4 Insider transaction Apr 14, 2025 Apr 11, 2025
ARS Annual report to shareholders Apr 7, 2025 Dec 31, 2024
DEFA14A Additional proxy material Apr 7, 2025 —
DEF 14A Proxy statement Apr 7, 2025 May 21, 2025
PRE 14A Preliminary proxy statement Mar 28, 2025 May 21, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 28, 2025 Feb 26, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 25, 2025 Feb 22, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 18, 2025
4 Insider transaction Feb 20, 2025 Feb 19, 2025
4 Insider transaction Feb 14, 2025 Feb 12, 2025
144 Notice of proposed sale Feb 13, 2025 —
10-K Annual report Feb 12, 2025 Dec 31, 2024

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
ALKS (Nasdaq)
Fiscal year ends
December 31
Headquarters
Dublin 4, Ireland
SEC filer status
Large accelerated filer
SEC CIK
1520262
Former names
ANTLER SCIENCE TWO PLC (until Aug 5, 2011); Antler Science Two Ltd (until Aug 2, 2011)

Other Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.